| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/14/2004 | CN1489586A Indazolyl-substituted pyrroline compounds as kinase inhibitor |
| 04/14/2004 | CN1489583A Novel physiologically active substance |
| 04/14/2004 | CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives |
| 04/14/2004 | CN1489580A Imidazole derivatives |
| 04/14/2004 | CN1489579A 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 04/14/2004 | CN1489463A Novel crystal forms of atorvastatin hemi-calcium and process for their preparation as well as novel process for preparing other forms |
| 04/14/2004 | CN1488631A Cyclic-aliphatic epoxy compound containing pheneylethylene cinnamyl or maleimide functional group |
| 04/14/2004 | CN1145625C Process for the production of tert-buty1 (E)-(6[2-[4-(4-fluorophenyl)-6-isopropyl-2[methyl(methyl sulfonyl)amino]pyrimidin5-yl](4R,65)-2,2-dimethyl[1,3]dioxan-4-yl]acetate ]) |
| 04/14/2004 | CN1145616C Novel amino-triazole compound, its preparation method and drug composition containing them |
| 04/13/2004 | US6720351 1h-indole-2-carboxylic acid (2-(benzyl(methyl)amino) -2-oxo-1-phenylethyl)amides; triamide microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) inhibitors; obesity; antilipemic agents |
| 04/13/2004 | US6720335 Sulfonamide inhibitors of aspartyl protease |
| 04/13/2004 | US6720329 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) |
| 04/13/2004 | US6720328 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) |
| 04/13/2004 | US6720327 Lactone integrin antagonists |
| 04/13/2004 | US6720321 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 04/13/2004 | US6720320 Phenoxypropylamine compounds |
| 04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/13/2004 | US6720317 Inhibitors of factor Xa |
| 04/13/2004 | US6719926 Chromene compound |
| 04/13/2004 | US6719339 Vehicle protection assembly |
| 04/13/2004 | CA2276747C Methods and devices for the reduction of small organic compounds from blood products |
| 04/11/2004 | WO2004033703A1 Novel macrophage foam cell formation inhibitor fka-25 and process for producing the same |
| 04/11/2004 | CA2461942A1 Novel fka-25 substance having inhibitory action against formation of the foam macrophage and a process for production thereof |
| 04/08/2004 | WO2004029579A2 Fluorescent labeling reagents with multiple donors and acceptors |
| 04/08/2004 | WO2004029578A2 Energy transfer dyes, terminators and use thereof |
| 04/08/2004 | WO2004029045A2 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof |
| 04/08/2004 | WO2004029026A1 Pyridine derivatives as cb2 receptor modulators |
| 04/08/2004 | WO2004028530A1 N-substituted heterocyclic amines as modulators of chemokine receptor activity |
| 04/08/2004 | WO2004028459A2 Piperidine derivatives |
| 04/08/2004 | WO2004028445A2 Processes for preparing 1,3-dioxolane nucleosides |
| 04/08/2004 | WO2004017961A3 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 04/08/2004 | WO2003106452A3 Antagonists of melanin concentrating hormone receptor |
| 04/08/2004 | WO2003101392A3 Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003068732A3 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds |
| 04/08/2004 | WO2003057225A3 Phosphate transport inhibitors |
| 04/08/2004 | WO2003051276B1 Therapeutic heterocycles |
| 04/08/2004 | WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 04/08/2004 | US20040068122 Delta1-pyrrolines used as pesticides |
| 04/08/2004 | US20040068121 A key intermediate in the synthesis of atorvastatin calcium |
| 04/08/2004 | US20040068117 Process for the preparation of (pyridinylidene)-phthalides |
| 04/08/2004 | US20040068109 Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration |
| 04/08/2004 | US20040068003 Compounds useful for the inhibition of ALDH |
| 04/08/2004 | US20040067999 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 04/08/2004 | US20040067996 Antiarthritic agents; osteoporosis; antitumor agents; antiulcer agents; antiinflammatory agents |
| 04/08/2004 | US20040067985 Anticancer agents |
| 04/08/2004 | US20040067983 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia |
| 04/08/2004 | US20040067976 Compounds useful for treating Hepatitis C virus |
| 04/08/2004 | US20040067964 Antiinflammatory agents |
| 04/08/2004 | US20040067961 Organ grafting; antiarthritic agents; inflammatory bowel disease |
| 04/08/2004 | US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 04/08/2004 | US20040067944 Antiarrhythmia agents |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/08/2004 | US20040067935 N-substituted heterocyclic amines as modulators of chemokine receptor activity |
| 04/08/2004 | US20040067914 R-NSAID esters and their use |
| 04/08/2004 | US20040067531 Methods of modulating protein tyrosine kinase function with substituted indolinone compounds |
| 04/08/2004 | US20040065866 Low viscosity; solubility at low temperature; low voltage display device |
| 04/08/2004 | CA2751086A1 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof |
| 04/08/2004 | CA2500231A1 Pyridine derivatives as cb2 receptor modulators |
| 04/08/2004 | CA2499876A1 Piperidine derivatives |
| 04/07/2004 | EP1404669A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 04/07/2004 | EP1404666A1 4-substituted-picolinic acid amide derivatives useful as fungicides |
| 04/07/2004 | EP1404653A1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 04/07/2004 | EP1404339A2 Method for treating fibrotic diseases or other indications vi |
| 04/07/2004 | EP1404335A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 04/07/2004 | EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors |
| 04/07/2004 | EP1404329A1 Substituted 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 04/07/2004 | EP1404321A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 04/07/2004 | EP1214307B1 4-oxybenzopyran derivative |
| 04/07/2004 | EP1185272B1 Novel use of 1-[4-(5-cyanoindol-3yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiological acceptable salts for the treatment of bipolar disorders and mania |
| 04/07/2004 | EP1149087B1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use |
| 04/07/2004 | CN1487934A 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487924A Farnesyl transferase inhibitors |
| 04/07/2004 | CN1487922A Process for the preparation of heterocgclic indene analogs |
| 04/07/2004 | CN1487921A Preparation of non-crystalline at orvastatin calcium |
| 04/07/2004 | CN1487920A Deltal-pyrrolines used as pesticides |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/07/2004 | CN1144791C Triazole compounds and its application as dopamine-D3-ligands |
| 04/07/2004 | CN1144789C Pyrrolidine and piperidine derivatives, producing process and application thereof |
| 04/07/2004 | CN1144786C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/06/2004 | US6716992 Free radical curable; adhesives |
| 04/06/2004 | US6716991 Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation |
| 04/06/2004 | US6716990 Process and intermediates for the preparation of imidazopyridines |
| 04/06/2004 | US6716987 Phosphodiesterase iv inhibitors |
| 04/06/2004 | US6716985 Alcoholism, psychological disorders |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716851 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof |
| 04/06/2004 | US6716850 Non-nucleoside reverse transcriptase inhibitors |
| 04/06/2004 | US6716847 Antiallergens, antiinflammatory |
| 04/06/2004 | US6716845 Barbituric acid derivatives |
| 04/06/2004 | US6716841 Nitrogen containing heterobicycles as factor Xa inhibitors |
| 04/06/2004 | US6716837 Heterocyclic compounds for the treatment of migraine |
| 04/06/2004 | US6716832 Arylphenyl-substituted cyclic ketoenols |
| 04/06/2004 | US6716628 Chondrogenesis promoters and indolin-2-one derivatives |
| 04/06/2004 | US6716413 Indole compounds as tissue-specific exogenous optical agents |
| 04/06/2004 | US6716257 Oxidation dyes, which are used for treatment of human hair |
| 04/06/2004 | CA2124306C Quinazolinone derivatives |
| 04/06/2004 | CA2105937C Pyrazine preparation |
| 04/01/2004 | WO2004027046A2 Methods of producing 4-amino-3-mercapto-triazoles |